Fig. 2From: Impact of renin–angiotensin–aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertensionThe Kaplan–Meier analysis according to whether receive ACEI/ARB therapy. A All-cause mortality; B MAEs; C CV death; D Non-CV death; E Stroke. ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin II receptor blocker; CV: cardiovascular; MAEs: major adverse eventsBack to article page